Free shipping on all orders over $ 500

Acoramidis

Cat. No. M10775
Acoramidis Structure
Size Price Availability Quantity
5mg USD 300  USD300 In stock
10mg USD 480  USD480 In stock
25mg USD 950  USD950 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Acoramidis (AG10) is an orally active, selective stabilizer of the thyroxine transporter (TTR) that is effective against both wild-type and V1221 mutant types.

Chemical Information
Molecular Weight 292.31
Formula C15H17FN2O3
CAS Number 1446711-81-4
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] COVIDSurg Collaborative, et al. Anaesthesia. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

[2] COVIDSurg Collaborative, et al. Anaesthesia. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study

[3] COVIDSurg Collaborative, et al. Anaesthesia. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

[4] Julio Rosenstock, et al. N Engl J Med. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

[5] Bernard Zinman, et al. N Engl J Med. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Related Transthyretin (TTR) Products
Eplontersen

Eplontersen is an N-acetylgalactosamine (GalNAc3)-suffixed antisense oligonucleotide (ASO) that targets the mRNA of the thyroxine transporter protein, TTR, and inhibits both variant and wild-type TTR production. It can be used in studies related to amyloidotic polyneuropathy.

WT-TTR inhibitor 1

WT-TTR inhibitor 1 is a wild-type Transthyretin (WT-TTR) inhibitor with 29.05% inhibition at 100 μM.

AS-Patisiran

Patisiran is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA.

Vutrisiran

Vutrisiran is a liver-directed small interfering RNA (siRNA) that targets transthyretin protein (TTR) mRNA and can be used in TTR-mediated amyloidosis studies.

Patisiran

Patisiran is a small double-stranded interfering RNA that targets sequences within the Transthyretin (TTR) messenger RNA and specifically inhibits hepatic synthesis of mutant and wild-type TTR. It can be used to study hereditary TTR amyloidosis.

  Catalog
Abmole Inhibitor Catalog




Keywords: Acoramidis supplier, Transthyretin (TTR), inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.